Posts in Member News
GBBO finalist and chemist Dr Josh Smalley to headline live edible chemistry demo at CHEMUK 2025 with Asynt

Asynt is delighted to announce a unique and inspiring live demo at this year’s highly anticipated CHEMUK exhibition, taking place on 21st–22nd May 2025 at the NEC, Birmingham. Visitors to Stand H102 on day two will be treated to a special “edible chemistry” demo, presented by Dr Josh Smalley, chemist, science communicator, and finalist on The Great British Bake Off.

Read More
ScotBio takes algae from pond to plate with development of protein product

The Team at ScotBio and researchers from the Scottish Centre for Food Development and Innovation (SCFDI) at Queen Margaret University have collaborated to assess the functional profile of a sustainable protein-based ingredient. This includes assessing its emulsifying and binding properties and its application in various food products. The project was supported by feasibility funding from the Industrial Biotechnology Innovation Centre (IBioIC).

Read More
EvoSelect®, A Machine Learning Enzyme Engineering Tool is Released

Isomerase has announced the launch of EvoSelect®, a machine learning-guided enzyme engineering platform designed to accelerate development timelines, enhance performance under industrial conditions, and reduce the cost and complexity of enzyme optimisation. EvoSelect® forms part of Isomerase’s broader IsoZym™ platform, an end-to-end offering that spans protein design, expression, and scale-up.

Read More
IFS Maven Equity Finance and the Scottish National Investment Bank back NCIMB with £1.7 million investment to drive growth

Aberdeen-based microbiology services provider and internationally recognised bacterial culture collection NCIMB Ltd has secured a £1.7m investment from the Investment Fund for Scotland, managed by Maven Capital Partners (“Maven”) and the Scottish National Investment Bank. The Maven team were first introduced to NCIMB at an IFS Roadshow in Aberdeen, hosted by the British Business Bank.

Read More
Concinnity Genetics raises £3m to establish unique RNA-based control systems for precise control of gene therapies in oversubscribed round

Concinnity Genetics, an Edinburgh-based gene control company, is thrilled to announce the closure of its oversubscribed £3m seed funding round. The investment was led by Eos Advisory with support from Scottish Enterprise, Old College Capital (OCC) - the University of Edinburgh’s in-house venture investment fund, and Maven Capital Partners.

Read More
Member NewsValerie Evans
Carbogenics Secures Nearly Half a Million Pounds to Drive Global Growth

University of Edinburgh spinout Carbogenics, a leading innovator in sustainable biochar technology, is thrilled to announce the successful close of its latest funding round, securing just under half a million pounds. This significant milestone reflects the confidence of both existing and new investors in Carbogenics’ mission to revolutionise sustainable solutions and expand its global footprint.

Read More
Member NewsValerie Evans
Lab-based “gut” model to help study of health-promoting bacteria being developed by NCIMB and The Rowett Institute in new KTP project

Aberdeen-based biotechnology company NCIMB is collaborating with the pioneering Rowett Institute to develop a tool that will improve understanding of microbes that have important roles in human health and disease, and support development of new treatments for inflammatory bowel disease, liver disease and cancer. The work has received funding from Innovate UK.

Read More
Member NewsValerie Evans